MF Researcher Database

Researcher Database

Advance

Yano Satoshi

■FacultyNeurology
■PositionAssociate Professor
Last Updated :2025/04/01

Researcher

基本情報

Profile and Settings

  • 氏名

    Yano Satoshi

Affiliation

  • Neurology, Associate Professor

Location

  • Northern Yokohama Hospital

Degree

  • Doctor of Medical Science, Showa University, Mar. 2008

Achievements

Published Papers

  • Cascade process mediated by left hippocampus and left superior frontal gyrus affects relationship between aging and cognitive dysfunction., KOKUDAI Yumika;HONMA Motoyasu;MASAOKA Yuri;YOSHIDA M;SUGIYAMA H;YOSHIKAWA Akira;KOIWA N;KUBOTA Satomi;IIZUKA Natsuko;WADA Sayaka;KAMIJO Shotaro;UCHIDA Yuki;YANO Satoshi;IDA M;ONO Kenjiro;IZUMIZAKI Masahiko, BMC Neurosci, 22(1):75, Dec. 2021, Peer-reviewed, DOI:10.1186/s12868-021-00680-x
  • Toxic amyloid β42 conformer may accelerate the onset of Alzheimer's disease in the preclinical stage, FUTAMURA Akinori;HIEDA Sotaro;MORI Yukiko;KASUGA Kensaku;SUGIMOTO Azusa;KASAI Hideyo;KURODA Takeshi;YANO Satoshi;TSUJI Mayumi;IKEUCHI Takeshi;IRIE Kazuhiro;ONO Kenjiro, J Alzheimers Dis, 80(2):639 - 646, Mar. 2021, Peer-reviewed
  • Serum BDNF as a potential biomarker of Alzheimer's disease: verification through assessment of serum, cerebrospinal fluid, and medial temporal lobe atrophy, MORI Yukiko;TSUJI Mayumi;OGUCHI Tatsunori;KASUGA Kensaku;Kimura Atsushi;KIMURA Atsushi;FUTAMURA Akinori;SUGIMOTO Azusa;KASAI Hideyo;KURODA Takeshi;YANO Satoshi;HIEDA Sotaro;KIUCHI Yuji;IKEUCHI Takeshi;ONO Kenjiro, Front Neurol, :653267, Mar. 2021, Peer-reviewed
  • High molecular weight amyloid β1-42 oligomers induce neurotoxicity via plasma membrane damage, YASUMOTO Taro;TAKAMURA Yusaku;TSUJI Mayumi;WATANABE-NAKAYAMA Takahiro;IMAMURA Keiko;INOUE Haruhisa;NAKAMURA Shiro;INOUE Tomio;KIMURA Atsushi;YANO Satoshi;NISHIJO Hisao;KIUCHI Yuji;TEPLOW David B;ONO Kenjiro, FASEB J, 33(8):9220 - 9234, Aug. 2019, Peer-reviewed
  • High serum high-density lipoprotein-cholesterol is associated with memory function and gyrification of insular and frontal opercular cortex in an elderly memory-clinic population., KINNO Ryuta;MORI Yukiko;KUBOTA Satomi;NOMOTO Shohei;FUTAMURA Akinori;SHIROMARU Azusa;KURODA Takeshi;YANO Satoshi;ISHIGAKI Seiichiro;MURAKAMI Hidetomo;BABA Yasuhiko;ONO Kenjiro, Neuroimage Clin, 22:e101746, Mar. 2019, Peer-reviewed
  • Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of 123I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson's Disease Patients., Murakami Hidetomo;Kimura Atsushi;Yasumoto Taro;Miki Ayako;Yamamoto Ken;Ito Naohito;Momma Yutaro;Owan Yoshiyuki;Yano Satoshi;Ono Kenjiro, Frontiers in aging neuroscience, 10:412, Dec. 2018, Peer-reviewed
  • Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of 123 I-MIBG during myocardial scintigraphy in drug naïve Parkinson's disease., MURAKAMI Hidetomo;YAMAMOTO Ken;YASUMOTO Taro;KIMURA Atsushi;SAKAE Yoshiki;NOMOTO Shohei;KUBOTA Satomi;WATANABE Daishi;WATANABE Keiko;SAITO Yu;YANO Satoshi;ONO Kenjiro, J Neural Transm (Vienna), 125(10):1511 - 1514, Oct. 2018, Peer-reviewed
  • Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro., SHOZAWA Hidenobu;OGUCHI Tatsunori;TSUJI Mayumi;YANO Satoshi;KIUCHI Yuji;ONO Kenjiro, Neurosci Lett, 677:19 - 25, Jun. 2018, Peer-reviewed
  • Differential Effects of the Factor Structure of the Wechsler Memory Scale-Revised on the Cortical Thickness and Complexity of Patients Aged Over 75 Years in a Memory Clinic Setting., KINNO Ryuta;SHIROMARU Azusa;MORI Yukiko;FUTAMURA Akinori;KURODA Takeshi;YANO Satoshi;MURAKAMI Hidetomo;ONO Kenjiro, Front Aging Neurosci, 9:e405, Dec. 2017, Peer-reviewed
  • Accumulation of 123I-Ioflupane is a useful marker of the efficacy of selegiline monotherapy in drug-naïve Parkinson’s disease., MURAKAMI Hidetomo;NOHARA Tetsuhito;UCHIYAMA Masanobu;OWAN Yoshiyuki;FUTAMURA Akinori;SHIROMARU Azusa;TSUKADA Setsuro;SAITO Yu;KURODA Takeshi;YANO Satoshi;ISHIGAKI Seiichiro;KATOH Hirotaka;MUNECHIKA Jiro;OHGIYA Yoshimitsu;GOKAN Takehiko;ONO Kenjiro, Front Aging Neurosci, 9:321, Sep. 2017, Peer-reviewed
  • Efficacy of levetiracetam in primary hemifacial spasm., KURODA Takeshi;SAITO Yu;FUJITA Kazuhisa;YANO Satoshi;ISHIGAKI Seiichiro;KATOH Hirotaka;MURAKAMI Hidetomo;ONO Kenjiro, J Clin Neurosci, 34:213 - 215, Jul. 2016, Peer-reviewed

Presentations

  • 血清BDNFのアルツハイマー病のバイオマーカーの可能性, 森　友紀子;辻　まゆみ;小口　達敬;春日　健作;木村　篤史;二村　明徳;杉本　あずさ;笠井　英世;黒田　岳志;矢野　怜;稗田　宗太郎;木内　祐二;池内　健;小野　賢二郎, 第40回日本認知症学会学術集会, 26 Nov. 2021, 東京・LIVE配信・オンデマンド配信
  • High molecular weight amyloid β oligomer induces disruption and structural change of cell membrane, YASUMOTO Taro;TAKAMURA Yusaku;TSUJI Mayumi;NAKAYAMA Takahiro;IMAMURA Keiko;INOUE Haruhisa;NAKAMURA Shiro;INOUE Tomio;KIMURA Atsushi;YANO Satoshi;NISHIJO Hisao;KIUCHI Yuji;TEPLOW David B;ONO Kenjiro, 第61回日本神経学会学術大会, 31 Aug. 2020, 岡山
  • High molecular weight amyloid β1-42 oligomers induce neurotoxicity via plasma membrane damage, YASUMOTO Taro;TAKAMURA Yusaku;TSUJI Mayumi;NAKAYAMA Takahiro;IMAMURA Keiko;INOUE Haruhisa;NAKAMURA Shiro;INOUE Tomio;KIMURA Michael Atsushi;YANO Satoshi;NISHIJO Hisao;KIUCHI Yuji;TEPLOW David B;ONO Kenjiro, Alzheimer's Association International Conference 2020, 26 Jul. 2020, Virtual Event
  • Vitamin B12 may prevent Aβ oligomer-induced neurotoxicity in Alzheimer's Disease, KIMURA Michael Atsushi;TSUJI Mayumi;YASUMOTO Taro;OGUCHI Tatsunori;MORI Yukiko;YANO Satoshi;KINNO Ryuta;NAKAMURA Shiro;INOUE Tomio;TEPLOW David B;KIUCHI Yuji;ONO Kenjiro, Alzheimer's Association International Conference 2020, 26 Jul. 2020, Virtual Event
  • 高分子Aβオリゴマーは細胞膜傷害を介して神経細胞毒性を発揮する, 安本　太郎;高村　雄策;辻　まゆみ;中山　隆宏;今村　恵子;井上　治久;中村　史朗;井上　富雄;木村　篤史;矢野　怜;西条　寿夫;木内　祐二;テプロフ　デイビッド;小野　賢二郎, 第38回日本認知症学会学術集会, 07 Nov. 2019, 東京
  • Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro, SHOZAWA Hidenobu;OGUCHI Tatsunori;TSUJI Mayumi;YANO Satoshi;KIUCHI Yuji;ONO Kenjiro, The 14th International Conference on Alzheimer's and Parkinson's Diseases, 30 Mar. 2019, Lisbon
  • パーキンソニズムで発症した神経梅毒の66歳男性例, 井藤　尚仁;四郎丸　あずさ;山本　謙;森　友紀子;二村　明徳;矢野　怜;村上　秀友;小野　賢二郎, 第223回日本神経学会関東・甲信越地方会, 02 Dec. 2017, 東京
  • 進行性非流暢性/失文法性失語の脳血流部位に関する研究, 金野　竜太;黒川　信二;大湾　喜行;二村　明徳;四郎丸　あずさ;笠井　英世;黒田　岳志;矢野　怜;石垣　征一郎;村上　秀友;小野　賢二郎, 第21回日本神経精神医学会, 17 Sep. 2016, 熊本
  • Levetiracetamが有効であった顔面痙攣の2症例, 黒田　岳志;齋藤　悠;藤田　和久;矢野　怜;石垣　征一郎;加藤　大貴;村上　秀友;河村　満, 第33回日本神経治療学会総会, 27 Nov. 2015, 名古屋
  • 無菌性髄膜炎の経過中に可逆性の頭部MRI異常信号域と尿閉を伴った31歳女性例, 齋藤　悠;村上　秀友;所澤　任修;二村　明徳;黒田　岳志;矢野　怜;石垣　征一郎;加藤　大貴;河村　満, 第20回日本神経感染症学会総会学術集会, 22 Oct. 2015, 長野
  • 急性期再開通療法を施行した患者の病型分類による転帰：自検例43例, 栗城　綾子;加藤　大貴;水間　啓太;斉藤　悠;黒田　岳志;矢野　怜;奥村　浩隆;神谷　雄己;河村　満, 第39回日本脳卒中学会総会, 13 Mar. 2014, 大阪

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.